These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rare germline variants in known melanoma susceptibility genes in familial melanoma. Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293 [TBL] [Abstract][Full Text] [Related]
6. Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes. Yu Y; Hu H; Chen JS; Hu F; Fowler J; Scheet P; Zhao H; Huff CD Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2247-2254. PubMed ID: 29317335 [TBL] [Abstract][Full Text] [Related]
7. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families. Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295 [TBL] [Abstract][Full Text] [Related]
8. POLE mutations in families predisposed to cutaneous melanoma. Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma. Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers. Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532 [TBL] [Abstract][Full Text] [Related]
11. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma. Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490 [TBL] [Abstract][Full Text] [Related]
12. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
13. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700 [TBL] [Abstract][Full Text] [Related]
14. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study. Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811 [TBL] [Abstract][Full Text] [Related]
15. Cancer risks associated with the germline MITF(E318K) variant. Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548 [TBL] [Abstract][Full Text] [Related]
16. A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma. Salgado C; Kwesi-Maliepaard EM; Jochemsen AG; Visser M; Harland M; van Leeuwen F; van Doorn R; Gruis N Melanoma Res; 2019 Dec; 29(6):582-589. PubMed ID: 31524790 [TBL] [Abstract][Full Text] [Related]
17. Functional Common and Rare Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832 [TBL] [Abstract][Full Text] [Related]
19. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers. Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767 [TBL] [Abstract][Full Text] [Related]